Merck’s anti-PD-1 therapy Keytruda won marketing clearance from the U.S. Food and Drug Administration in November 2020 for treating triple‑negative breast cancer.

The investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women, according to results reported by ViiV Healthcare.

POPSUGAR, the No. 1 most engaged-with women’s lifestyle site in the United States, together with TherapeuticsMD Inc. launched a new women’s health destination.

Among high-income countries, the United States has the highest maternal mortality rates, reflecting deaths from complications of pregnancy and childbirth, according to a new international comparison from the Commonwealth Fund.

Pregnant women are at increased risk for severe illness from COVID-19, according to a study from MMWR (Morbidity and Mortality Weekly Report).

Healthcare communications agencies in the United States and overseas promoted and hired top-level talent for management roles.

UK-based Fishawack Health reorganized business operations as a leading global commercialization partner for the life sciences industry.

As the COVID-19 pandemic causes immense changes that are altering health systems and ways of interacting with consumers, a deep understanding of data-led experience design becomes a necessity for contemporary health companies.

ObsEva SA’s board of directors appointed Brian O’Callaghan to succeed Dr. Ernest Loumaye as CEO and member of the company’s executive committee, effective December 1.

NovaGo Therapeutics, a development-stage biotech company with a proprietary platform to stimulate blood vessel and nerve growth, appointed Ian Metcalfe as CEO.